These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5643297)

  • 1. Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.
    Bergsagel DE; Robertson GL; Hasselback R
    Can Med Assoc J; 1968 Mar; 98(11):532-8. PubMed ID: 5643297
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in peripheral blood composition following single and repeated courses of intermittent cancer chemotherapy.
    Wiktor-Jedrzejczak W; Siekierzynski M; Rychowiecka E; Bukowska B; Czarnecki C
    Med Interne; 1982; 20(4):289-94. PubMed ID: 6985497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of lung cancer].
    Dement'eva NP
    Sov Med; 1984; (11):55-61. PubMed ID: 6084308
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy for extensive non-small cell carcinomas of the lung.
    Davis S; Rambotti P; Park YK
    Cancer Treat Rep; 1981; 65(11-12):955-8. PubMed ID: 7028257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of lung cancer with Endoxan, with reference to the effect of massive intermittent administration].
    Matsuda M; Nishihara H; Komatsu T; Hattori S; Terasawa T
    Saishin Igaku; 1967 Aug; 22(8):1808-20. PubMed ID: 6081168
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correlation between the number of monocytes and granulocytes in the peripheral blood in lung cancer patients].
    Sukhanov IuS
    Probl Gematol Pereliv Krovi; 1976 Dec; 21(12):23-6. PubMed ID: 1024199
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.
    Knost JA; Greco FA; Hande KR; Richardson RL; Fer MF; Oldham RK
    Cancer Treat Rep; 1981; 65(11-12):941-5. PubMed ID: 7028255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of toxic doses of selected antineoplastic drugs on the hematopoietic system of mice after splenectomy].
    Robak T
    Acta Haematol Pol; 1980; 11(3):181-7. PubMed ID: 7445921
    [No Abstract]   [Full Text] [Related]  

  • 9. [Kinetic patterns of changes in the number of peripheral blood leukocytes in lung cancer patients after treatment with cyclophosphane combined with cystaphos].
    Disvetova VV; Levitin EI; Trakhtenberg AKh; Batinov IN
    Izv Akad Nauk SSSR Biol; 1977; (3):351-6. PubMed ID: 886069
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy of lung cancer].
    Bychkov MB; Melikidze GN; Denisov LE
    Vopr Onkol; 1972; 18(9):82. PubMed ID: 4197459
    [No Abstract]   [Full Text] [Related]  

  • 11. Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
    Green MR
    J Clin Oncol; 2008 Jul; 26(19):3112-3. PubMed ID: 18591551
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
    Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of combined treatment of advanced squamous cell carcinoma of the lung with vincristine, adriamycin and cyclophosphamide].
    Krawczyk K; Krochmal M; Pawlicki M; Kulpa J; Zielezińska A
    Pneumonol Pol; 1983 Feb; 51(2):107-11. PubMed ID: 6878054
    [No Abstract]   [Full Text] [Related]  

  • 14. Intermediate dose single agent cyclophosphamide chemotherapy of advanced breast cancer.
    Bramwell VH; Howell A; Anderson H; Rankin EM
    Clin Oncol; 1983 Sep; 9(3):251-6. PubMed ID: 6617000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer.
    Leighl NB; Goss GD; Lopez PG; Burkes RL; Dancey JE; Rahim YH; Rudinskas LC; Pouliot JF; Rodgers A; Pond GR; Shepherd FA
    Lung Cancer; 2006 Jun; 52(3):327-32. PubMed ID: 16597474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide effect on changes in rabbit peripheral blood in the development period.
    Maślińska D; Swierczyńska A; Koch I
    Acta Physiol Pol; 1983; 34(1):85-90. PubMed ID: 6637534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with large doses of Endoxan].
    Araujo E; Estevez R; Sanchez Suarez R; Chacon R; Gonzalez G
    Med Monatsschr; 1967 Aug; 21(8):371-3. PubMed ID: 5597100
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of intraoperative massive dose therapy on the postoperative condition].
    Schmidt D
    Wien Med Wochenschr; 1969 Jan; 119(1):15-8. PubMed ID: 5773406
    [No Abstract]   [Full Text] [Related]  

  • 19. [Excretion of thiophosphamide and cyclophosphane in lung cancer patients].
    Kas'ianenko IV; Pivniuk VM
    Vopr Onkol; 1974 Oct; 20(7):28-31. PubMed ID: 4212652
    [No Abstract]   [Full Text] [Related]  

  • 20. [Staining of blood smears with rivanol in patients suffering from bronchogenic neoplasms].
    Czerny K
    Gegenbaurs Morphol Jahrb; 1975; 121(2):209-13. PubMed ID: 54278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.